• A dynamic game of lymphatic filariasis prevention by voluntary use of insecticide treated nets
• A pilot study to address the mental health of persons living with lymphatic filariasis in Léogâne, Haiti: Implementing a chronic disease self-management program using a stepped-wedge cluster design
• A review of epidemiology of lymphatic filariasis in Nigeria
• Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study
• Active infection with Onchocerca volvulus and the linkage to epilepsy/nodding syndrome
• AI sees an end to filariasis
• ALTERNATIVE ROUTE OF TRANSMISSION AND HOST SPECIFICITY OF CYRTOSOMUM PENNERI IN FLORIDA'S INVASIVE LIZARDS
• An automated, high-resolution phenotypic assay for adult Brugia malayi and microfilaria
• An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale
• An evaluation of mental health integration in the neglected tropical diseases program in Zamfara, North-west Nigeria
• An unexpected case of a dog from Poland co-infected with Dirofilaria repens and Dirofilaria Immitis
• An Updated Economic Assessment of Moxidectin Treatment Strategies for Onchocerciasis Elimination
• Analysis of diagnostic test outcomes in a large loiasis cohort from an endemic region: Serological tests are often false negative in hyper-microfilaremic infections
• Assessment of Culicidae collection methods for xenomonitoring lymphatic filariasis in malaria co-infection context in Burkina Faso
• Association of haemato-biochemical indices and blood composite ratios with microfilaridermia in Onchocerciasis patients
• Bioactive components in Psidium guajava extracts elicit biotoxic attributes and distinct antioxidant enzyme modulation in the larvae of vectors of lymphatic filariasis and dengue
• Case of subconjunctival dirofilariasis
• Challenges and Solutions: Total Knee Replacement in Patients with Chronic Lymphatic Filariasis: A Case Report
• Clinical and epidemiological features of imported loiasis in Beijing: a report from patients returned from Africa
• Community Involvement in Onchocerciasis Post-elimination Surveillance in Bududa District, Eastern Uganda: A cross-sectional study
• Community Perceptions of Blackfly Nuisance and Acceptability of the "Slash and Clear" Vector Control Approach in the Ntui Health District of Cameroon: A Qualitative Study
• Community's knowledge, perceptions and preventive practices on Onchocerciasis in Jimma zone, Ethiopia, formative mixed study
• Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research
• Detection and dynamics of tumor necrosis factor alpha in the diagnosis and treatment of canine heartworm disease
• Detection of Wuchereria bancrofti infection in mosquitoes in areas co-endemic with Brugia malayi in Balasore district, Odisha, India
• Development of a novel rodent model for dog heartworm microfilaremia using the severe-combined immunodeficiency mouse
• Differential susceptibility of Onchocerca ochengi adult male worms to flubendazole in gerbils and hamsters
• Dirofilaria immitis and Onchocercidae spp. in wild felids from Brazil
• Dirofilariasis presenting as pleural effusion: a rare case report with unusual manifestations and treatment modalities
• Distinguishing recrudescence from reinfection in lymphatic filariasis
• Doxycycline, a role in the treatment of onchocerciasis-associated epilepsy?
• Edge Artificial Intelligence (AI) for real-time automatic quantification of filariasis in mobile microscopy
• Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study
• Efficacy of moxidectin, using various dose regimens, against JYD-34, a macrocyclic lactone resistant isolate of Dirofilaria immitis
• Emerging human pulmonary dirofilariasis in Hungary: a single center experience
• Entomological assessment in 'hotspots' of four lymphatic filariasis endemic districts, Central Nepal during post-MDA surveillance
• Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting
• Evaluation of coagulation and platelet activation state and function in heartworm-infected dogs
• Evaluation of diagnostic techniques for early detection of heartworm in experimentally infected dogs: identification of Dirofilaria immitis-derived microRNA in the initial 28 weeks post-inoculation
• Evaluation of feline heartworm disease based on gross necropsy, serology, pulmonary histopathology, and radiographic evidence in adult shelter cats in northeastern Alabama
• Field laboratory comparison of STANDARD Q Filariasis Antigen Test (QFAT) with Bioline Filariasis Test Strip (FTS) for the detection of Lymphatic Filariasis in Samoa, 2023
• Financial hardship among patients suffering from neglected tropical diseases: A systematic review and meta-analysis of global literature
• Gnathostoma infection after ingestion of raw fish is a probable cause of eosinophilic meningitis in the Brazilian Amazon
• Heartworm disease in domestic dogs in Estonia: indication of local circulation of the zoonotic parasite Dirofilaria immitis farther north than previously reported
• Heartworm-, Flea-, and Tick-associated Diseases in Dogs: A Review of Common Parasites and Drug Classes Prophylactic Against Them
• Heterogeneity in elimination efforts could increase the risk of resurgence of lymphatic filariasis in Madagascar
• Hiding in plain sight: Microfilaria in a case of splenic littoral cell angioma
• Histological validation of in-vivo larvicidal efficacy of marine Streptomyces sp. RD06 secondary metabolites against filariasis causing Culex quinquefasciatus and statistical media optimization for larvicidal derivatives production
• How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
• Identification and characterisation of Mansonella perstans in the Volta Region of Ghana
• Immune targeting of filarial glutaredoxin through a multi-epitope peptide-based vaccine: A reverse vaccinology approach
• Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone
• Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study
• Impact of conflict on the elimination targets of lymphatic filariasis, schistosomiasis and soil-transmitted helminths in Cabo Delgado province, Mozambique
• Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators
• Impediments to compliance during filariasis mass drug administration-Observations and recommendations to accelerate filariasis elimination in India
• Improving access to melarsomine therapy: treating canine heartworm infection in a high-volume, outpatient community clinic setting
• Investigating Dirofilaria immitis isolates infecting domestic canines and their susceptibility/resistance patterns to macrocyclic lactones in the northern region of the Mississippi Delta area (southeast Missouri)
• Leprosy and lymphatic filariasis-related disability and psychosocial burden in northern Mozambique
• Lessons from integrating mental health as part of lymphatic filariasis morbidity management and disability prevention services in Jigawa State, Nigeria
• Low diagnostic performance of thick blood smears of 50 µl in comparison with direct examination of 10 µl blood and the leukoconcentration technique of 5ml blood among loiasis-suspected patients with low microfilaremia in Gabon, Central Africa, using the S
• Lymphatic Filariasis
• Microfilaruria of Dirofilaria immitis in a dog from Italy
• Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
• Modelling the cost of engage & treat and test & treat strategies towards the elimination of lymphatic filariasis in Ghana
• Molecular identification and genetic variability of equine and bovine ocular setariasis in india: molecular profiling by mitochondrial genes
• Molecular insights and antibody response to Dr20/22 in dogs naturally infected with Dirofilaria repens
• Ocular Brugia pahangi Filariasis Complicated by Severe Macular Damage in Thailand: Case Report and Literature Review
• Ocular Dirofilariasis in Migrant from Sri Lanka, Australia
• Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Gha
• Onchocerciasis in the Cameroon-Chad border area after more than 20 years of annual mass ivermectin distribution
• Onchocerciasis-associated epilepsy and biomarkers
• Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on <em> </em><em>Onchocerca volvulus</em>
• Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration
• Operational research to inform post-validation surveillance of lymphatic filariasis in Tonga study protocol: History of lymphatic filariasis elimination, rational, objectives, and design
• Otterly diverse - A high diversity of Dracunculus species (Spirurida: Dracunculoidea) in North American river otters (Lontra canadensis)
• Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings
• Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control
• Prophylaxis Against Heartworm Infection and Flea or Tick Infestation in Dogs: Single Agents and Combination-Drug Products
• Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti
• Repeated sensitization of mice with microfilariae of Litomosoides sigmodontis induces pulmonary eosinophilia in an IL-33-dependent manner
• Sero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August-September 2018
• Spirocerca lupi draft genome, vaccine and anthelmintic targets
• Strain-level variations of Dirofilaria immitis microfilariae in two biochemical assays
• Subconjunctival <em>Dirofilaria</em> masquerading as nodular scleritis
• Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy
• Synthesizing environmental, epidemiological and vector and parasite genetic data to assist decision making for disease elimination
• The effectiveness of albendazole against hookworm infections and the impact of bi-annual treatment on anaemia and body mass index of school children in the Kpandai district of northern Ghana
• The effects of selected neglected tropical diseases on economic performance at the macrolevel in Africa
• The impact of mosquito sampling strategies on molecular xenomonitoring prevalence for filariasis: a systematic review
• The impact of the National Programme to Eliminate Lymphatic Filariasis on filariasis morbidity in Sri Lanka: Comparison of current status with retrospective data following the elimination of lymphatic filariasis as a public health problem
• The national distribution of lymphatic filariasis cases in Malawi using patient mapping and geostatistical modelling
• The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation
• Thelazia callipaeda Eyeworms in American Black Bear, Pennsylvania, USA, 2023
• Thubunaea acostai sp. nov. (Nematoda: Physalopteridae) from the lizard Liolaemus gracielae (Squamata: Iguania: Liolaemidae) in Argentina
• Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment
• Unpacking Immune Modulation as a Site of Therapeutics Innovation for Nematode Parasite <em>Wuchereria bancrofti</em>: A Temporal Quantitative Phosphoproteomics Profiling of Macrophage Migration Inhibitory Factor 2
• Whole genome amplification and sequencing of individual Dirofilaria immitis microfilariae
• Wuchereria bancrofti Lymphatic Filariasis, Barrancabermeja, Colombia, 2023
• Zoonotic Mansonella ozzardi in Raccoons, Costa Rica, 2019-2022